Slate Path Capital LP - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 106 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Slate Path Capital LP ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,105,683
-33.9%
7,157,6010.0%0.15%
-42.3%
Q4 2022$4,696,818
-23.7%
7,157,6010.0%0.25%
-36.8%
Q3 2022$6,156,000
+56.7%
7,157,6010.0%0.40%
+63.3%
Q2 2022$3,928,000
-50.6%
7,157,6010.0%0.24%
-39.8%
Q1 2022$7,945,000
-35.5%
7,157,6010.0%0.41%
-36.9%
Q4 2021$12,311,000
-44.0%
7,157,6010.0%0.64%
-35.7%
Q3 2021$21,974,000
-21.3%
7,157,6010.0%1.00%
-35.7%
Q2 2021$27,915,000
+61.5%
7,157,601
+15.5%
1.56%
+39.1%
Q1 2021$17,287,000
-8.8%
6,196,0630.0%1.12%
+9.3%
Q4 2020$18,960,000
-49.7%
6,196,0630.0%1.03%
-52.1%
Q3 2020$37,672,000
+432.9%
6,196,063
+418.0%
2.14%
+414.1%
Q2 2020$7,069,000
+123.0%
1,196,0630.0%0.42%
+71.6%
Q1 2020$3,170,000
-70.3%
1,196,063
+35.9%
0.24%
-65.6%
Q3 2019$10,666,000
+30.5%
880,000
+23.2%
0.71%
+92.4%
Q2 2019$8,176,000714,0180.37%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$6,156,0000.40%
MFN Partners Management, LP 3,389,215$2,915,0000.13%
Diametric Capital, LP 243,711$210,0000.11%
Artal Group S.A. 2,779,122$2,391,0000.10%
Intrinsic Value Partners, LLC 48,315$42,0000.06%
TRUSTCORE FINANCIAL SERVICES, LLC 292,645$252,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$99,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 92,541$80,0000.00%
COLONY GROUP LLC 102,884$88,0000.00%
ACADIAN ASSET MANAGEMENT LLC 231,952$198,0000.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders